The Valley Desk

NCT06073821 · Interventional trial

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

Overall registry status Active not recruiting

Phase 3

Conditions CLL

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov